Urinary Retention
Conditions
Keywords
catheter, intermittent catheterization, bladder
Brief summary
The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.
Detailed description
The purpose of this crossover study is to compare the urinary flow speed of two different female catheters manufactured by Coloplast, the "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" vs "14 Fr Coloplast Micro Zone Luja Female Catheter" in patients that use intermittent catheters to empty their bladder. Patients will be randomly assigned to group A or group B using a closed-envelope randomization method. Group A will self catheter with Luja, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with SpeediCath. Group B will self catheter with SpeediCath, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with Luja. Outcomes will be measured with office uroflow device.
Interventions
DEVICEColoplast Micro Zone Luja Female Catheter
clean self-catheterization with 14 Fr Coloplast micro zone Luja female urinary catheter
DEVICEColoplast SpeediCath Female Catheter
clean self-catheterization with 14 Fr two eyelet Coloplast SpeediCath female urinary catheter
Sponsors
Wake Forest University Health Sciences
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Female * Regular use of intermittent catheters to empty bladder, for at least 1 month before enrolment * Age 18 years or older * Required to adhere to the intervention procedure and not participate in any other clinical studies throughout the duration of this study
Exclusion criteria
* Severe urinary tract abnormalities (e.g. excessive production of urinary mucus/sediments/debris) * Hypersensitive to the ingredients in the catheters being tested * Recent surgery, within 3 months * Currently being treated for urinary tract infection * Being pregnant or breastfeeding * Non-English speaking
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Urinary flow duration | Day 1 | Amount of time (seconds) it takes the urine to be released. The normal urinary flow duration for women is 15-18 ml/sec. A lower average flow rate could indicate a problem with the bladder or urinary tract. |
| Total Urine Volume | Day 1 | total urine volume (mL) measured by uroflow device |
| Peak Flow Rate | Day 1 | Peak flow (mL/sec) measured by uroflow device. Normal peak urine flow rates typically range from 15 to 25 mL/sec for women. Reduced flow rates or a slow stream can indicate urinary tract obstruction or other issues. |
| Time to Peak Flow | Day 1 | Time (seconds) to peak flow measured by uroflow device. A normal peak flow rate for women is typically between 15 and 25 mL/sec. A lower rate may indicate a blockage or obstruction in the urinary tract. |
| Mean Flow | Day 1 | Mean flow (mL/sec) measured by uroflow device. Normal mean urine flow rates typically range from 15 to 25 mL/sec for women. A slow or low flow rate may mean there is an obstruction at the bladder neck or in the urethra or a weak bladder. |
| Total Urine voiding time | Day 1 | Total time (seconds) to void urine from beginning of urine flow to the end of flow, measured by uroflow device. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measuring patient's satisfaction of using catheter-Part a | Day 1 | Patient's preference of catheter type by using the Patient Global Impression of Improvement (PGI-I) scale |
| Measuring patient's satisfaction of using catheter-Part b | Day 1 | Patient's Satisfaction and Comments on Use of Luja Catheter |
Countries
United States
Contacts
CONTACTMichael Kennelly, MD
CONTACTZahra Bahrani-Mostafvai, PhD
PRINCIPAL_INVESTIGATORMichael Kennelly, MD
Wake Forest University Health Sciences
Outcome results
None listed